Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by W Jeffrey Fessel
Minority Variants Associated With Transmitted and Acquired HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor Resistance: Implications for the Use of Second-Generation Nonnucleoside Reverse Transcriptase Inhibitors
Journal of Acquired Immune Deficiency Syndromes
Infectious Diseases
Pharmacology
Related publications
Selection of Nonnucleoside Reverse Transcriptase Inhibitor-Associated Mutations in HIV-1 Subtype C: Evidence of Etravirine Cross-Resistance
AIDS
Infectious Diseases
Allergy
Immunology
Novel Mutations L228I and Y232H Cause Nonnucleoside Reverse Transcriptase Inhibitor Resistance in Combinational Pattern
AIDS Research and Human Retroviruses
Virology
Infectious Diseases
Immunology
Nonnucleoside Reverse Transcriptase Inhibitors Reduce HIV-1 Production From Latently Infected Resting CD4 + T Cells Following Latency Reversal
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Human Immunodeficiency Virus Type 1 Resistance or Cross-Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Currently Under Development as Microbicides
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Human Biotransformation of the Nonnucleoside Reverse Transcriptase Inhibitor Rilpivirine and a Cross-Species Metabolism Comparison
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Comprehensive Mutant Enzyme and Viral Variant Assessment of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Resistance to Nonnucleoside Inhibitors.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Rational Dose Selection for a Nonnucleoside Reverse Transcriptase Inhibitor Through Use of Population Pharmacokinetic Modeling and Monte Carlo Simulation
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Anti-Hiv Drugs and Resistance: Inhibitors of HIV-1 Reverse Transcriptase and Protease
Inhibition of Human Immunodeficiency Virus Type 1 Infection by the Candidate Microbicide Dapivirine, a Nonnucleoside Reverse Transcriptase Inhibitor
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
